Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Acute Brain Injuries

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Acute Brain Injuries in 7 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Research Excerpts

ExcerptRelevanceReference
"These findings suggest that traumatic injury in the infant rat brain is mediated by endogenous excitotoxins (Glu and aspartate) acting at NMDA receptors and can be substantially mitigated by timely treatment with NMDA receptor antagonists."1.29Prevention of trauma-induced neurodegeneration in infant rat brain. ( Ikonomidou, C; Kirby, C; Labruyere, J; Olney, JW; Qin, Y, 1996)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's3 (42.86)18.2507
2000's3 (42.86)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oertel, M1
Kelly, DF1
Lee, JH1
Glenn, TC1
Vespa, PM1
Martin, NA1
Bernert, H1
Turski, L3
Ikonomidou, C3
Qin, Y1
Labruyere, J1
Kirby, C1
Olney, JW2
Pohl, D1
Bittigau, P1
Ishimaru, MJ1
Stadthaus, D1
Hübner, C1
Myers, WA1
Churchill, JD1
Muja, N1
Garraghty, PE1
Stefovska, V1
Faden, AI1
Demediuk, P1
Panter, SS1
Vink, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Changes of the Short Portable Mental Status Questionnaire (SPMSQ-E) After Ketamine Administration on Ophthalmic Surgery in Geriatric Population.[NCT02049411]Phase 280 participants (Actual)Interventional2013-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

7 other studies available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Acute Brain Injuries

ArticleYear
Is CPP therapy beneficial for all patients with high ICP?
    Acta neurochirurgica. Supplement, 2002, Volume: 81

    Topics: Anticonvulsants; Blood Pressure; Brain Injuries; Humans; Intracranial Hypertension; Intracranial Pre

2002
Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, May-28, Volume: 93, Issue:11

    Topics: Animals; Brain Injuries; Cerebral Cortex; Disease Models, Animal; Excitatory Amino Acid Antagonists;

1996
Prevention of trauma-induced neurodegeneration in infant rat brain.
    Pediatric research, 1996, Volume: 39, Issue:6

    Topics: Animals; Brain Injuries; Dendrites; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Piperazi

1996
N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, Mar-02, Volume: 96, Issue:5

    Topics: Animals; Apoptosis; Brain; Brain Injuries; Caudate Nucleus; Disease Models, Animal; Dizocilpine Male

1999
Role of NMDA receptors in adult primate cortical somatosensory plasticity.
    The Journal of comparative neurology, 2000, Mar-20, Volume: 418, Issue:4

    Topics: Animals; Brain Injuries; Brain Mapping; Denervation; Excitatory Amino Acid Antagonists; Median Nerve

2000
Neuronal death enhanced by N-methyl-D-aspartate antagonists.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Nov-07, Volume: 97, Issue:23

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain Injuries; Cell Death; Dizoc

2000
The role of excitatory amino acids and NMDA receptors in traumatic brain injury.
    Science (New York, N.Y.), 1989, May-19, Volume: 244, Issue:4906

    Topics: Animals; Aspartic Acid; Binding, Competitive; Brain; Brain Injuries; Dextrorphan; Glutamates; Glutam

1989